{"address1": "Shanghai Pharmaceutical Building", "address2": "No. 200 Taicang Road", "city": "Shanghai", "zip": "200020", "country": "China", "phone": "86 21 6373 0908", "fax": "86 21 6328 9333", "website": "https://www.sphchina.com", "industry": "Medical Distribution", "industryKey": "medical-distribution", "industryDisp": "Medical Distribution", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores, and online drug business. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.", "fullTimeEmployees": 47877, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bo  Shen", "age": 50, "title": "President, CFO, Head of the Accounting Department & Executive Director", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": 5799000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yongzhong  Li", "age": 53, "title": "VP & Executive Director", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 6521000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tao  Zhong", "age": 51, "title": "VP, Board Secretary & Joint Company Secretary", "yearBorn": 1972, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dongming  Li", "age": 54, "title": "Vice President", "yearBorn": 1969, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shuai  Shao", "age": 35, "title": "Vice President", "yearBorn": 1988, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shunjiang  Yu", "title": "Chief Medical Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ming  Dong", "age": 47, "title": "Executive Director", "yearBorn": 1976, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pui Kiu  Wong", "title": "Joint Company Secretary", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ying  Ke", "title": "Director & General Manager of R&D Management Center", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Linqiong  Dong", "title": "Securities Affairs Representative", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 2, "shareHolderRightsRisk": 9, "overallRisk": 6, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 17.42, "open": 17.45, "dayLow": 17.4, "dayHigh": 17.59, "regularMarketPreviousClose": 17.42, "regularMarketOpen": 17.45, "regularMarketDayLow": 17.4, "regularMarketDayHigh": 17.59, "dividendRate": 0.61, "dividendYield": 0.035, "exDividendDate": 1689811200, "payoutRatio": 0.5126, "fiveYearAvgDividendYield": 2.4, "beta": 0.252, "trailingPE": 14.6470585, "forwardPE": 10.759259, "volume": 10576984, "regularMarketVolume": 10576984, "averageVolume": 12505638, "averageVolume10days": 13098666, "averageDailyVolume10Day": 13098666, "bid": 17.43, "ask": 17.44, "marketCap": 58730737664, "fiftyTwoWeekLow": 15.36, "fiftyTwoWeekHigh": 23.98, "priceToSalesTrailing12Months": 0.23042713, "fiftyDayAverage": 17.2412, "twoHundredDayAverage": 18.4348, "trailingAnnualDividendRate": 0.61, "trailingAnnualDividendYield": 0.035017222, "currency": "CNY", "enterpriseValue": 88505958400, "profitMargins": 0.01805, "floatShares": 1646154352, "sharesOutstanding": 2784229888, "heldPercentInsiders": 0.65097, "heldPercentInstitutions": 0.06603, "impliedSharesOutstanding": 3353530112, "bookValue": 18.5, "priceToBook": 0.94216216, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "earningsQuarterlyGrowth": 0.061, "netIncomeToCommon": 4600016384, "trailingEps": 1.19, "forwardEps": 1.62, "pegRatio": 1.05, "lastSplitFactor": "1.2:1", "lastSplitDate": 1187222400, "enterpriseToRevenue": 0.347, "enterpriseToEbitda": 8.692, "52WeekChange": -0.15272373, "SandP52WeekChange": 0.32311738, "lastDividendValue": 0.61, "lastDividendDate": 1689811200, "exchange": "SHH", "quoteType": "EQUITY", "symbol": "601607.SS", "underlyingSymbol": "601607.SS", "shortName": "SHANGHAI PHARMACEUTICALS HOLDIN", "longName": "Shanghai Pharmaceuticals Holding Co., Ltd", "firstTradeDateEpochUtc": 764472600, "timeZoneFullName": "Asia/Shanghai", "timeZoneShortName": "CST", "uuid": "cb478da1-64d3-331e-b1a3-acbf1a82c140", "messageBoardId": "finmb_20356815", "gmtOffSetMilliseconds": 28800000, "currentPrice": 17.43, "targetHighPrice": 26.8, "targetLowPrice": 13.0, "targetMeanPrice": 21.36, "targetMedianPrice": 22.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 40667344896, "totalCashPerShare": 10.981, "ebitda": 10182917120, "totalDebt": 52990939136, "quickRatio": 1.004, "currentRatio": 1.345, "totalRevenue": 254877696000, "debtToEquity": 66.12, "revenuePerShare": 67.833, "returnOnAssets": 0.027379999, "returnOnEquity": 0.07606, "freeCashflow": 395258304, "operatingCashflow": 7204575744, "earningsGrowth": -0.022, "revenueGrowth": 0.032, "grossMargins": 0.12422, "ebitdaMargins": 0.03995, "operatingMargins": 0.036310002, "financialCurrency": "CNY", "trailingPegRatio": null}